Awareness of human papilloma virus, cervical cancer and HPV vaccine in healthcare workers and students of medical and nursing schools

Year 2012, , 318 - 325, 01.09.2012

Nilgün Güdücü Gökçenur Gönenç Herman İşçi Alin Başgül Yiğiter İlkkan Dünder

https://doi.org/10.5799/ahinjs.01.2012.03.0171

Cited By: 2

Abstract

Objectives: Establishment of the knowledge and the need to make conscious in medicine students, nursing students and nurses due to the effective role of updating conscious of the health workers, we aimed to assess the knowledge of nurses and students of İstanbul Bilim University and affiliated hospitals about HPV and cervical cancer. Materials and methods: Because healthcare personnel illuminate and influences the public, the survey was conducted to medicine students of the first three years, nursing students and nurses. The reason of choosing the first three years of medicine students is with the begining of the gynecology courses at the 4th year of education in medical faculty, learning takes the place of awareness. Totally 743 participants were asked to survey but 603 subjects responded (81.2%) then the surveys that was not asked for the identity information were taken into consideration Results: Nurses and students of nursing had better knowledge about smear test when compared to students of medicine (first 3 years) and other healthcare personnel. Only 52% accepted to get a daughter vaccinated. The main reasons for vaccine rejection were the concerns about vaccine safety (41%), cost of the vaccine (10%) and sexual promiscuity (5%) after vaccination. Religious aspects were not considered as an obstacle. Conclusions: The awareness of HPV, cervical cancer and HPV vaccination should be increased.

Keywords

HPV, HPV vaccine, cervical cancer, knowledge

Sağlık çalışanları, tıp öğrencileri ve hemşirelik öğrencilerinde insan papilloma virüsü, servikal kanser ve HPV aşısı farkındalığı

Abstract

Amaç: Sağlık çalışanlarının halkı bilgilendirmedeki etkin rolü göz önüne alındığında hemşirelik öğrencileri, tıp öğrencileri ve hemşirelerin serviks kanseri, HPV ve HPV aşıları hakkındaki bilinç düzeyinin tespit edilmesini ve bilinçlendirme ihtiyacının araştırılmasını amaçladık ve İstanbul Bilim Üniversitesi öğrencileri ve afiliye hastanelerdeki sağlık çalışanlarının HPV ve serviks kanseri hakkındaki bilgilerini değerlendirdik. Gereç ve yöntem: Sağlık personeli, toplumu bilgilendirme ve yönlendirme yaptığı için, anket, tıp fakültesi ilk 3 yıl öğrencilerine, hemşirelik öğrencilerine ve hemşirelere yapıldı. Dördüncü sınıftan itibaren jinekoloji derslerinin başlamasıyla birlikte bilinç yerini bilgiye bıraktığı için sadece ilk üç yıldaki tıp öğrencileri seçilmiştir. Anket sorularını cevaplandırması istenen 743 katılımcının 603 tanesi (% 81,2) anketimizi cevaplamayı kabul etti. Daha sonra kimlik bilgisi istenmeyen anketler değerlendirmeye alındı. Bulgular: Hemşireler ve hemşirelik öğrencileri, tıp fakültesi öğrencileri (ilk 3 yıl) ve diğer sağlık çalışanlarıyla kıyaslandığında smear test konusunda daha bilgiliydiler. Katılımcıların sadece %52\'si kızlarının aşılanmasına itiraz etmeyeceğini beyan etti. Aşıyı kabul etmeyenlerin kabul etmeme gerekçeleri aşının güvenirliliği hakkındaki endişeler (% 41), aşının maliyeti (%10) ve aşılanmadan sonra cinsel ilişki serbestisinin onaylanması fikri (%5) idi. Dini konular engel olarak değerlendirilmedi. Sonuç: HPV, serviks kanseri ve HPV aşıları hakkındaki farkındalığın artırılması gerekmektedir.

Keywords

HPV, HPV aşıları, serviks kanseri, bilinç düzeyi

References

• Dursun P, Senger SS, Arslan H, et al. Human Papillo- mavirus (HPV) prevalence and types among Turkish women at a gynecology outpatient unit. BMC Infect Dis 2009; 9(1): 191-5.
• Orth G, Jablonska S, Jarzabek-Chorzelska M. et al. Characteristics of the lesions and risk of malignant conversion associated with the type of human papil- lomavirus involved in epidermo- dysplasia verrucifor- mis. Cancer Res 1979;39(3):1074-82.
• Catellsague X, Diaz M, de Sanjose S, et al. Worldwide human papillomavirus etiology of cervical adenocar- cinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst 2006;98(5):303-15.
• Markowitz LE, Dunne EF, Saraiya M, et al. Quadriva- lent human papillomavirus vaccine:recommendations of the advisory committee on immunization practices. Centers for Disease Control and Prevention, Depart- ment of Health and Human services, MMWR Recomm Rep 2007;56(RR-2):1-24.
• Baseman J, Koutsky L. The epidemiology of human papillomavirus infections. J Clin Virol 2005;32(1):16- 24
• Noakes K, Yarwood J, Salisbury D. Parental response to the introduction of a vaccine against human papil- loma virus. Hum Vaccin 2006;2(2):243-8
• Walsh CD, Gera A, Shah M, Sharma A, Powell JE, Wil- son S. Public knowledge and attitudes towards Hu- man Papillomavirus (HPV) vaccination. BMC Public Health 2008;8(3):368-42.
• Di Giuseppe G, Abbate R, Liguori G, Albano L, Angelillo IF. Human papillomavirus and vaccination: knowledge, attitudes and behavioural intention in adolescents and young women in Italy. Br J Cancer 2008;99(2):225-6.
• Wong LP, Sam IC. Ethnically diverse female univer- sity students’ knowledge and attitudes toward hu- man papillomavirus (HPV), HPV vaccination and cervical cancer. Eur J Obstet Gynecol Reprod Biol 2010;148(1):90-5.
• Inal MM, Köse S, Yildirim Y, et al. The relationship between human papillomavirus infection and cervical intraepithelial neoplasia in Turkish women. Int J Gyne- col Cancer 2007;17(6):1266-70.
• Podratz KC. State of the gynecologic cancers: fifth annual report to the women of America 2007 Gyne- cologic Cancer Foundation. Available at: http://www. wcn.org/downloads/state_of_the_state_2007.pdf
• Lu B, Kumar A, Castellsagué X, Giuliano. Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a sys- tematic review & meta-analysis. ARBMC Infect Dis 2011;12(1):11-3.
• Eren F, Erenus M, Bas E, Ahiskali R, Yoldemir T. Prevalence of HPV infection by cytologic diagnosis and HPV DNA extraction and prevalence of the HPV genotypes detected in urban Turkish women. Int J Gynaecol Obstet 2010;109(3):235-8.
• Dinas K, Nasioutziki M, Arvanitidou O, et al. Aware- ness of human papillomavirus infection, testing and vaccination in midwives and midwifery students in Greece. J Obstet Gynaecol 2009;29(6):542-6.
• Ilter E, Celik A, Haliloglu B, et al Women’s knowledge of Pap smear test and human papillomavirus: ac- ceptance of HPV vaccination to themselves and their daughters in an Islamic society. Int J Gynecol Cancer 2010;20(6):1058-62.
• Weiss TW, Rosenthal SL, Zimet GD. Attitudes toward HPV Vaccination among Women Aged 27 to 45. ISRN Obstet Gynecol 2011;2011:670318.
• Prislin R, Nader PR, DeGuire M, et al. Physicians’ immunization knowledge, attitudes and practices: a valid and internally consistent measurement tool. Am J Prev Med 1999;17(2):151-2
• Dursun P, Altuntas B, Kuscu E, Ayhan A. Women’s knowledge about human papillomavirus and their ac- ceptance of HPV vaccine. Aust N Z J Obstet Gynaecol 2009;49(2):202-6.
• Kahn JA, Ding L, Huang B, Zimet GP, Rosenthal SL, Frazier AL. Mothers’ intention for their daugh- ters and themselves to receive human papilloma- virus vaccine: a national study of nurses. Pediatrics 2009;123(6):1439-45.
• Oh JK, Lim MK, Yun EH, Lee EH, Shin HR. Aware- ness of and attitude towards human papillomavirus in- fection and vaccination for cervical cancer prevention among adult males and females in Korea: a nation- wide interwiev survey. Vaccine 2010;28(7):1854-60.
• Woodhall SC, Lehtinen M, Verho T, Huhtala H, Hok- kanen M, Kosunen E. Anticipated acceptance of HPV vaccination at the baseline of implementation:a sur- vey of parental and adolescent knowledge and atti- tudes in Finland. J Adolesc Health 2007;40(5):466-9.
• Kahn JA, Cooper HP, Vadarampil ST, et al. Human papillomavirus vaccine recommendations and agree- ment with mandated human papillomavirus vaccina- tion for 11-to-12-year-old girls: a statewide survey of Texas physicians. Cancer Epidemiol Biomarkers Prev 2009;18(8):2325-32.
• Caskey R, Lindau ST, Alexander GC. Knowledge and early adoption of the HPV vaccine among girls and young women: results of a national survey. J Adolesc Health 2009 Nov;45(5):453-62.
• Zimet GD, Mays RM, Fortenberry JD. Vaccines against sexually transmitted infections: promise and problems of the magic bullets for prevention and con- trol. Sex Transm Dis 2000 Jan;27(1):49-52.
• Gerend MA, Weibley E, Bland H. Parental response to human papillomavirus vaccine availability: uptake and intentions. J Adolesc Health 2009 Nov;45(5):528- 31.
• Gootvall M, Larsson M, Höglund AT, Tyden T. High HPV vaccine acceptance despite low awareness among Swedish upper secondary school students. Eur J Contracept Reprod Health Care 2009;14(6):399- 405.
• Constantine NA, Jerman P. Acceptance of human papillomavirus vaccination among Californian parents of daughters: a representative statewide analysis. J Adolesc Health 2007;40(2):108-15.
• Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: a theory-informed, sysytematic review. Prev Med 2007;45(2-3):107-14.
• Zimet GD, Liddon N, Rosenthal SL, Lazcano-Ponce E, Allen B. Psychosocial aspects of vaccine accept- ability. Vaccine 2006;24(2):201-9.
• Leddy MA, Anderson BL, Gall S, Schulkin J. Obste- trician-gynecologists and the HPV vaccine: practice patterns, beliefs, and knowledge. J Pediatr Adolesc Gynecol 2009;22(4):239-46.
• Davis K, Dickman ED, Ferris D, Dias JK. Human pap- illomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents. J Low Genit Tract Dis 2004;8(3):188-94.
• Zimet GD: Improving adolescent health: focus on HPV vaccine acceptance. J Adolesc Health 2005 Dec;37(6Suppl):17-23.
• Rosenthal D, Dyson S, Pitts M, Garland S. Challenges to accepting a human papillomavirus (HPV) vaccine:a qualitative study of Australian women. Women Health 2007;45(2):59-73.
• Ferris DG, Cromwell L, Waller JL, Horn L. Most par- ents do not think receiving human papillomavirus vac- cine would encourage sexual activity in their children. J Low Genit Tract Dis 2010;14(3):179-84
• Hoover D, Carfioli B, Moench EA. Attitudes of adoles- cent/young adult women toward human papillomavi- rus vaccination and clinical trials. Health Care Women Int 2000;21(5):375-91.
• Stark A, Gregorie L, Pilarski R, Zarbo A, Gaba A, Lancaster WD. Human papillomavirus, cervical can- cer and women’s knowledge. Cancer Detect Prev 2008;32(1):15-22.
• Chelimo C, Wouldes TA. Human papillomavirus knowledge and awareness among undergraduates in healthcare training in New Zealand. N Z Med J 2009;122(1304):33-45.
• Juraskova I, Bari RA, O’Brien MT, McCaffery KJ. HPV vaccine promotion: does referring to both cervical can- cer and warts affect intended and actual vaccination behavior. Womens Health Issues 2011;21(1):71-9.
• Dempsey AF. Human papillomavirus: the usefulness of risk factors in determining who should get vacci- nated. Rev Obstet Gynecol 2008;1(3):122-8.